Ligand ID: DEX Drugbank ID: DB00443(Betamethasone)DB01234(Dexamethasone) Indication:Topical use (cream, lotion and ointment): for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. ;Injection: for the treatment of endocrine disorders, rheumatic D=disorders, collagen diseases, dermatologic diseases, allergic statesc, ophthalmic diseases, gastrointestinal diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, cerebral edema. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 5r7z | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.45A | 19.50 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.77A | 19.32 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.75A | 19.32 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.66A | 19.32 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.46A | 19.29 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.69A | 19.32 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.68A | 21.85 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.70A | 22.15 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.79A | 21.85 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.77A | 22.15 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.48A | 19.50 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 3 / 3 | MET A 264GLN A 273TYR A 237 | 1.77A | 19.50 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.45A | 19.50 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.79A | 21.85 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.66A | 21.85 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.69A | 22.15 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 3 / 3 | MET A 264GLN A 273TYR A 237 | 1.80A | 19.50 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.77A | 22.15 | None | ||
![]() | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) | 6m17 | ACE2RECEPTOR BINDINGDOMAIN (Homosapiens;SARS-CoV-2) | 5 / 12 | MET D 323GLY F 502GLN F 506ILE D 379PHE D 356 | 1.79A | 15.56 | None | ||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m17 | ACE2RECEPTOR BINDINGDOMAIN (Homosapiens;SARS-CoV-2) | 5 / 12 | MET D 323GLY F 502GLN F 506ILE D 379PHE D 356 | 1.74A | 15.37 | None | ||
![]() | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) | 6m17 | ACE2RECEPTOR BINDINGDOMAIN (Homosapiens;SARS-CoV-2) | 5 / 12 | MET D 323GLY F 502GLN F 506ILE D 379PHE D 356 | 1.70A | 16.01 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | MET D 264LEU D 205LEU D 242THR D 257ILE D 259 | 1.46A | 19.50 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.70A | 22.15 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY D 174VAL D 171CYH D 128ILE D 106PHE D 112 | 1.78A | 21.85 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.67A | 21.85 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | ASN B 231VAL B 204LEU B 268CYH B 265THR B 225 | 1.67A | 21.85 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | ASN B 231VAL B 204LEU B 268CYH B 265THR B 225 | 1.70A | 22.15 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY D 174VAL D 171CYH D 128ILE D 106PHE D 112 | 1.76A | 22.15 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | MET B 264LEU B 205LEU B 242THR B 257ILE B 259 | 1.45A | 19.50 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY C 174VAL C 171CYH C 128ILE C 106PHE C 112 | 1.80A | 21.85 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY B 174VAL B 171CYH B 128ILE B 106PHE B 112 | 1.79A | 22.15 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.45A | 19.50 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 3 / 3 | MET D 264GLN D 273TYR D 237 | 1.73A | 19.50 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | MET C 264LEU C 205LEU C 242THR C 257ILE C 259 | 1.55A | 19.50 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY C 174VAL C 171CYH C 128ILE C 106PHE C 112 | 1.77A | 22.15 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.68A | 22.15 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.76A | 22.15 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.79A | 21.85 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.66A | 21.85 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 3 / 3 | MET A 264GLN A 273TYR A 237 | 1.79A | 19.50 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.48A | 19.50 | None | ||
![]() | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | ASN A 695GLN A 789MET A 626MET A 633ILE A 757 | 1.66A | 13.61 | None | ||
![]() | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | MET A 666GLY A 670ARG A 392ILE A 539PHE A 504 | 1.60A | 13.61 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 6 | LEU A 212LEU A 146THR A 248VAL A 182 | 1.49A | 14.01 | None | ||
![]() | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | MET A 666GLY A 670ARG A 392ILE A 539PHE A 504 | 1.48A | 14.67 | None | ||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 5 | LEU A 731TRP A 290MET A 242LEU A 240 | 1.57A | 14.67 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6m71 | NSP7NSP8 (SARS-CoV-2) | 4 / 6 | LEU C 59LEU D 103THR C 9VAL C 12 | 1.46A | 19.43 | None | ||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | MET A 666GLY A 670ARG A 392ILE A 539PHE A 504 | 1.42A | 14.03 | None | ||
![]() | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | ASN A 695GLN A 789MET A 626MET A 633ILE A 757 | 1.73A | 14.67 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 6 | LEU A 731LEU A 723PHE A 745VAL A 472 | 1.54A | 14.01 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m71 | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | GLN C 19VAL C 22ARG C 21ILE C 68PHE D 92 | 1.61A | 16.87 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m71 | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | GLN C 19VAL C 22ARG C 21ILE C 68PHE D 92 | 1.58A | 16.87 | None | ||
![]() | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) | 6m71 | NSP12NSP7NSP8 (SARS-CoV-2) | 5 / 12 | ASN A 414GLN C 18MET D 87ARG C 21VAL A 844 | 1.73A | 14.35 | None | ||
![]() | 3MNO_A_DEXA784_2 (GLUCOCORTICOIDRECEPTOR) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 6 | LEU A 207TRP A 290MET A 242GLN A 210 | 1.76A | 13.80 | None | ||
![]() | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | LEU A 786ALA A 762MET A 794CYH A 622PHE A 694 | 1.79A | 14.01 | None | ||
![]() | 3GN8_A_DEXA247_1 (GLUCOCORTICOIDRECEPTOR 2) | 6m71 | NSP12NSP7NSP8 (SARS-CoV-2) | 5 / 12 | ASN A 414GLN C 18MET D 87ARG C 21VAL A 844 | 1.74A | 14.35 | None | ||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | ASN A 695GLN A 789MET A 626MET A 633ILE A 757 | 1.65A | 14.03 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6m71 | NSP7NSP8 (SARS-CoV-2) | 4 / 6 | LEU C 17LEU D 95PHE D 92VAL C 66 | 1.57A | 19.43 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6m71 | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | LEU A 372LEU A 371MET B 90THR A 538ILE A 536 | 1.78A | 14.67 | None | ||
![]() | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | ASN A 695GLN A 789MET A 626MET A 633ILE A 757 | 1.78A | 14.67 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 214GLN A 210VAL A 182LEU A 178THR A 148 | 1.69A | 13.80 | None | ||
![]() | 3MNP_A_DEXA784_2 (GLUCOCORTICOIDRECEPTOR) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 6 | LEU A 207TRP A 290MET A 242GLN A 210 | 1.78A | 14.12 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 6 | LEU A 240TRP A 290LEU A 245THR A 189 | 1.47A | 14.01 | None | ||
![]() | 3GN8_A_DEXA247_2 (GLUCOCORTICOIDRECEPTOR 2) | 6m71 | NSP12 (SARS-CoV-2) | 3 / 3 | MET A 601MET A 818PHE A 812 | 1.79A | 14.35 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 214GLN A 210VAL A 182LEU A 178THR A 148 | 1.70A | 14.12 | None | ||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASN B 317GLY B 594GLN B 613LEU C 858THR C 739 | 1.65A | 11.46 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASN B 317GLY B 594GLN B 613LEU C 858THR C 739 | 1.61A | 11.30 | None | ||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 5 | LEU A 916MET A1050LEU A1049GLN A 913 | 1.54A | 11.95 | None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | GLY A 857LEU A1004GLN A1011LEU A 767THR A 732 | 1.49A | 11.95 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 6 | LEU B1063LEU B 806THR B 881VAL B1033 | 0.78A | 11.40 | None | ||
![]() | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | GLN C1011ARG C1014ILE B 569PHE C 855LEU C 858 | 1.61A | 10.96 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | MET A 869GLN A 787TYR A 789 | 1.54A | 11.95 | None | ||
![]() | 3GN8_A_DEXA247_1 (GLUCOCORTICOIDRECEPTOR 2) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | LEU C 767GLY C 769GLN C1011THR C 732VAL C 860 | 1.62A | 11.02 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASN B 317GLY B 594GLN B 613LEU C 858THR C 739 | 1.62A | 11.46 | None | ||
![]() | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | LEU B 546ASN B 544ALA B 522LEU B 517PHE B 329 | 1.76A | 11.40 | None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 12 | ASN A 117LEU A 93LEU A 127CYH A 143THR A 146 | 1.74A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 6 | LEU B 153LEU B 10THR B 13VAL B 144 | 1.53A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 6 | LEU B 127LEU B 122THR B 146VAL B 142 | 1.61A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 12 | ASN A 117VAL A 36LEU A 127CYH A 143THR A 146 | 1.62A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 12 | ASN B 117VAL B 36LEU B 127CYH B 143THR B 146 | 1.62A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 12 | ASN A 117VAL A 36LEU A 127CYH A 143THR A 146 | 1.62A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 6 | LEU A 153LEU A 10THR A 13VAL A 144 | 1.61A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 12 | ASN B 117VAL B 36LEU B 127CYH B 143THR B 146 | 1.61A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 12 | ASN B 117LEU B 93LEU B 127CYH B 143THR B 146 | 1.76A | None | |||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | GLY A 885MET A 902LEU A1049ILE A 805PHE A 802 | 1.56A | 11.88 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | GLY A 885MET A 902LEU A1049ILE A 805PHE A 802 | 1.62A | 11.80 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | GLY A 885MET A 902LEU A1049ILE A 805PHE A 802 | 1.62A | 11.88 | None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | GLY A 857LEU A1004GLN A1011LEU A 767THR A 732 | 1.51A | 12.09 | None | ||
![]() | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASN A 928GLY A 799MET A 902PHE A 797ILE A 931 | 1.75A | 12.09 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 6 | LEU B1063LEU B 806THR B 881VAL B1033 | 0.82A | 11.35 | None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | GLY C 857LEU C1004GLN C1011LEU C 767THR C 732 | 1.51A | 12.09 | None | ||
![]() | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASN C 928GLY C 799MET C 902PHE C 797ILE C 931 | 1.76A | 12.09 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 6 | LEU A1063LEU A 806THR A 881VAL A1033 | 0.78A | 11.35 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | VAL A 120ARG A 190LEU A 118ILE A 235PHE A 201 | 1.64A | 11.65 | None | ||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | GLY B 885MET B 902LEU B1049ILE B 805PHE B 802 | 1.58A | 11.88 | None | ||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 5 | LEU B 916MET B1050LEU B1049GLN B 913 | 1.61A | 12.09 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | GLY A 885MET A 902LEU A1049ILE A 805PHE A 802 | 1.64A | 11.88 | None | ||
![]() | 3GN8_A_DEXA247_1 (GLUCOCORTICOIDRECEPTOR 2) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | LEU A 767GLY A 769GLN A1011THR A 732VAL A 860 | 1.65A | 11.32 | None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6w02 | NSP3 (SARS-CoV-2) | 5 / 12 | ASN B 117LEU B 93LEU B 127CYH B 143THR B 146 | 1.73A | 20.00 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6w02 | NSP3 (SARS-CoV-2) | 5 / 12 | ASN B 117VAL B 36LEU B 127CYH B 143THR B 146 | 1.59A | 20.08 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6w02 | NSP3 (SARS-CoV-2) | 5 / 12 | ASN B 117VAL B 36LEU B 127CYH B 143THR B 146 | 1.59A | 19.50 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 6 | LEU A6857LEU A7052THR A6891VAL A6865 | 1.74A | 20.69 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 6 | LEU A6852PHE A6991THR A6993VAL A6995 | 1.65A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 6 | TRP A7029PHE A7003THR A6993VAL A6995 | 1.64A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.79A | None | |||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 3 / 3 | MET A 264GLN A 273TYR A 237 | 1.79A | 19.50 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.60A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.77A | None | |||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.49A | 19.50 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.63A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 6 | LEU A 164LEU A 169THR A 13VAL A 144 | 1.64A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | ASN B 117VAL B 36LEU B 127CYH B 143THR B 146 | 1.60A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 6 | LEU B 127LEU B 122THR B 146VAL B 142 | 1.69A | 20.69 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 6 | LEU B 153LEU B 10THR B 13VAL B 144 | 1.67A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 6 | LEU A 153LEU A 10THR A 13VAL A 144 | 1.69A | 20.69 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | ASN A 117VAL A 36LEU A 127CYH A 143THR A 146 | 1.55A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | ASN B 117VAL B 36LEU B 127CYH B 143THR B 146 | 1.60A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 6 | LEU A 127LEU A 122THR A 146VAL A 142 | 1.68A | 20.69 | None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | ASN B 117LEU B 93LEU B 127CYH B 143THR B 146 | 1.75A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | ASN A 117VAL A 36LEU A 127CYH A 143THR A 146 | 1.55A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | ASN A 117LEU A 93LEU A 127CYH A 143THR A 146 | 1.71A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 6 | LEU B 164LEU B 169THR B 13VAL B 144 | 1.56A | None | |||
![]() | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | LEU C6909GLY C6911MET C6929THR C6880PHE C6901 | 1.66A | 19.71 | None NA C7104 ( 4.1A)SAM C7105 ( 3.5A)NoneNone | ||
![]() | 1P93_B_DEXB2999_2 (GLUCOCORTICOIDRECEPTOR) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 4 / 4 | LEU D4298MET D4316GLN C6885TYR D4349 | 1.77A | 16.98 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 6 | LEU A6852PHE A6991THR A6993VAL A6995 | 1.67A | 20.78 | None | ||
![]() | 3GN8_A_DEXA247_2 (GLUCOCORTICOIDRECEPTOR 2) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 3 / 3 | MET A7045MET B4316PHE A7043 | 1.80A | 18.86 | None | ||
![]() | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | LEU A6909GLY A6911MET A6929THR A6880PHE A6901 | 1.64A | 18.86 | NoneNoneSAM A7102 ( 3.5A)NoneNone | ||
![]() | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | LEU C6909GLY C6911MET C6929THR C6880PHE C6901 | 1.63A | 18.86 | None NA C7104 ( 4.1A)SAM C7105 ( 3.5A)NoneNone | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 3 / 3 | MET D4316GLN C6885TYR D4349 | 1.32A | 16.98 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 6 | LEU C6852PHE C6991THR C6993VAL C6995 | 1.64A | 20.78 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 6 | TRP A7029PHE A7003THR A6993VAL A6995 | 1.68A | 20.78 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 6 | LEU A6857LEU A7052THR A6891VAL A6865 | 1.74A | 20.78 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 6 | LEU A 162TRP A 93THR A 115VAL A 165 | 1.43A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 6 | LEU B 117LEU B 125PHE B 173VAL B 165 | 1.51A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 142VAL A 98LEU A 118ILE A 151PHE A 147 | 1.54A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 6 | LEU A 117LEU A 125PHE A 173VAL A 165 | 1.57A | None | |||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | LEU A 185LEU A 234GLN A 237GLN A 195ILE A 222 | 1.79A | 23.88 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 6 | LEU C 117LEU C 132THR C 168VAL C 165 | 1.53A | None | |||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | LEU A 117LEU A 113MET A 169THR A 277ILE A 285 | 1.65A | 23.88 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | LEU C 185LEU C 234GLN C 237GLN C 195ILE C 222 | 1.77A | 23.88 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 6 | LEU B 117LEU B 132THR B 168VAL B 165 | 1.52A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 6 | LEU C 117LEU C 125PHE C 173VAL C 165 | 1.50A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 6 | LEU A 117LEU A 132THR A 168VAL A 165 | 1.42A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6w9q | 3C-LIKE PROTEINASEPEPTIDE, NSP9 FUSION (SARS-CoV-2) | 4 / 6 | LEU A 103LEU A 9THR A 109VAL A 110 | 1.58A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6wcf | NSP3 (SARS-CoV-2) | 5 / 12 | ASN A 117LEU A 93LEU A 127CYH A 143THR A 146 | 1.75A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wcf | NSP3 (SARS-CoV-2) | 4 / 6 | LEU A 153LEU A 10THR A 13VAL A 144 | 1.55A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6wcf | NSP3 (SARS-CoV-2) | 5 / 12 | ASN A 117VAL A 36LEU A 127CYH A 143THR A 146 | 1.60A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6wcf | NSP3 (SARS-CoV-2) | 5 / 12 | ASN A 117VAL A 36LEU A 127CYH A 143THR A 146 | 1.60A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6wen | NSP3 (SARS-CoV-2) | 5 / 12 | ASN A 117LEU A 93LEU A 127CYH A 143THR A 146 | 1.76A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wen | NSP3 (SARS-CoV-2) | 4 / 6 | LEU A 164LEU A 169THR A 13VAL A 144 | 1.58A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6wen | NSP3 (SARS-CoV-2) | 5 / 12 | ASN A 117VAL A 36LEU A 127CYH A 143THR A 146 | 1.58A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6wen | NSP3 (SARS-CoV-2) | 5 / 12 | ASN A 117VAL A 36LEU A 127CYH A 143THR A 146 | 1.59A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wey | NSP3 (SARS-CoV-2) | 4 / 6 | LEU A 357LEU A 214THR A 217VAL A 348 | 1.63A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6wey | NSP3 (SARS-CoV-2) | 5 / 12 | ASN A 321VAL A 240LEU A 331CYH A 347THR A 350 | 1.61A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6wey | NSP3 (SARS-CoV-2) | 5 / 12 | ASN A 321VAL A 240LEU A 331CYH A 347THR A 350 | 1.61A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wiq | NSP7NSP8 (SARS-CoV-2) | 4 / 6 | LEU A 59LEU B 103THR A 9VAL A 12 | 1.55A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6wiq | NSP8 (SARS-CoV-2) | 5 / 12 | GLN B 158VAL B 167CYH B 142THR B 141PHE B 147 | 1.80A | None | |||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 6wiq | NSP7NSP8 (SARS-CoV-2) | 4 / 5 | LEU A 13MET B 94LEU B 95GLN B 88 | 1.63A | 16.03 | None | ||
![]() | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) | 6wiq | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | GLN A 19ARG B 80ILE A 68PHE B 92LEU B 91 | 1.72A | 16.18 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 6 | LEU A6852PHE A6991THR A6993VAL A6995 | 1.64A | None | |||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 3 / 3 | MET D4316GLN C6885TYR D4349 | 1.33A | 16.98 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 6 | TRP C7029PHE C7003THR C6993VAL C6995 | 1.65A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 6 | LEU C6852PHE C6991THR C6993VAL C6995 | 1.63A | None | |||
![]() | 1P93_B_DEXB2999_2 (GLUCOCORTICOIDRECEPTOR) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 4 / 4 | LEU D4298MET D4316GLN C6885TYR D4349 | 1.79A | 16.98 | None | ||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | GLY B 170GLN B 58LEU B 64GLN B 70LEU B 161 | 1.69A | None | |||
![]() | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 12 | LEU A6909GLY A6911MET A6929THR A6880PHE A6901 | 1.64A | 21.90 | None NA A7102 ( 4.2A)SFG A7103 ( 3.5A)NoneNone | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 6 | TRP C7029PHE C7003THR C6993VAL C6995 | 1.64A | None | |||
![]() | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 12 | LEU C6909GLY C6911MET C6929THR C6880PHE C6901 | 1.64A | 21.90 | None NA C7102 ( 4.2A)SFG C7103 ( 3.5A)NoneNone | ||
![]() | 1P93_B_DEXB2999_2 (GLUCOCORTICOIDRECEPTOR) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 4 / 4 | LEU D4298MET D4316GLN C6885TYR D4349 | 1.78A | 16.98 | None | ||
![]() | 3GN8_A_DEXA247_2 (GLUCOCORTICOIDRECEPTOR 2) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 3 / 3 | MET A7045MET B4316PHE A7043 | 1.79A | 21.90 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 3 / 3 | MET D4316GLN C6885TYR D4349 | 1.33A | 16.98 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 6 | LEU A6852PHE A6991THR A6993VAL A6995 | 1.65A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 6 | LEU C6852PHE C6991THR C6993VAL C6995 | 1.64A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 6 | LEU B 190LEU B 73THR B 121VAL B 183 | 1.61A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 6 | LEU A 190LEU A 73THR A 121VAL A 183 | 1.65A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.80A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.78A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.68A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.65A | None | |||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.46A | 19.50 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | LEU D 153LEU D 10THR D 13VAL D 144 | 1.62A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN B 117VAL B 36LEU B 127CYH B 143THR B 146 | 1.64A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN C 117LEU C 93LEU C 127CYH C 143THR C 146 | 1.74A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN D 117VAL D 36LEU D 127CYH D 143THR D 146 | 1.58A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN B 117VAL B 36LEU B 127CYH B 143THR B 146 | 1.64A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | LEU B 127LEU B 122THR B 146VAL B 142 | 1.66A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN A 117LEU A 93LEU A 127CYH A 143THR A 146 | 1.70A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN B 117LEU B 93LEU B 127CYH B 143THR B 146 | 1.75A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN A 117VAL A 36LEU A 127CYH A 143THR A 146 | 1.58A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | LEU C 127LEU C 122THR C 146VAL C 142 | 1.65A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN D 117VAL D 36LEU D 127CYH D 143THR D 146 | 1.57A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | LEU C 153LEU C 10THR C 13VAL C 144 | 1.66A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN C 117VAL C 36LEU C 127CYH C 143THR C 146 | 1.63A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN D 117LEU D 93LEU D 127CYH D 143THR D 146 | 1.69A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | LEU B 153LEU B 10THR B 13VAL B 144 | 1.64A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN C 117VAL C 36LEU C 127CYH C 143THR C 146 | 1.63A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | LEU A 127LEU A 122THR A 146VAL A 142 | 1.65A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 6 | LEU D 127LEU D 122THR D 146VAL D 142 | 1.63A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN A 117VAL A 36LEU A 127CYH A 143THR A 146 | 1.59A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 6 | LEU A6852PHE A6991THR A6993VAL A6995 | 1.59A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | GLY A6962VAL A6859ARG A7081LEU A7050ILE A7005 | 1.74A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 6 | LEU A6857LEU A7052THR A6891VAL A6865 | 1.62A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | GLY A6962VAL A6859ARG A7081LEU A7050ILE A7005 | 1.72A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 4 / 6 | LEU A 17LEU B 95PHE B 92VAL A 66 | 1.61A | None | |||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 4 / 5 | LEU C 13MET D 94LEU D 95GLN D 88 | 1.75A | 16.03 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 4 / 6 | LEU C 59LEU D 103THR C 9VAL C 12 | 1.54A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 4 / 6 | LEU A 59LEU B 103THR A 9VAL A 12 | 1.57A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wqd | NSP7 (SARS-CoV-2) | 4 / 6 | LEU A 13TRP A 29LEU A 40VAL C 11 | 1.66A | None | |||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 4 / 5 | LEU A 13MET B 94LEU B 95GLN B 88 | 1.66A | 16.03 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.77A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.78A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.68A | None | |||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.51A | 19.50 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.71A | None | |||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 5 / 12 | LEU A 117LEU A 113MET A 169THR A 277ILE A 285 | 1.70A | 23.88 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 4 / 6 | LEU A 117LEU A 132THR A 168VAL A 165 | 1.51A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 4 / 6 | LEU A 117LEU A 125PHE A 173VAL A 165 | 1.43A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6y2e | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.67A | 22.15 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6y2g | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.65A | 21.85 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 6y2g | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 3 / 3 | MET B 264GLN B 273TYR B 237 | 1.64A | 19.50 | None | ||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 6y2g | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 5 | LEU A 272TRP A 218MET A 276GLN A 273 | 1.54A | 19.50 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.75A | 18.94 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.67A | 18.94 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.70A | 18.94 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.78A | 18.94 | None | ||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.47A | 19.29 | None | ||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 4 / 5 | LEU C 13MET D 94LEU D 95GLN D 88 | 1.67A | 14.18 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 4 / 6 | LEU A 59LEU B 103THR A 9VAL A 12 | 1.57A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 4 / 6 | LEU A 13TRP A 29LEU A 40VAL C 11 | 1.65A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 4 / 6 | LEU C 59LEU D 103THR C 9VAL C 12 | 1.57A | None | |||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 4 / 5 | LEU A 13MET B 94LEU B 95GLN B 88 | 1.63A | 14.18 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 12 | GLY C 64GLN C 63VAL C 58LEU C 17THR D 84 | 1.79A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 4 / 6 | LEU C 13TRP C 29LEU C 40VAL A 11 | 1.64A | None | |||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6yi3 | NUCLEOPROTEIN (SARS-CoV-2) | 5 / 12 | LEU A 119GLY A 135ARG A 67THR A 36ILE A 34 | 1.29A | 19.05 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 6 | LEU A 390LEU A 518THR A 430VAL A 382 | 1.49A | DMS A 905 (-4.9A)NoneNoneDMS A 905 (-4.3A) | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 6 | LEU A 387LEU A 368PHE A 338VAL A 524 | 1.54A | DMS A 905 ( 4.2A)NoneNoneNone | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 6 | LEU E 387LEU E 368PHE E 338VAL E 524 | 1.50A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.69A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.72A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.75A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.73A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 6 | LEU E 387LEU E 368PHE E 338VAL E 524 | 1.51A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 6 | LEU A 387LEU A 368PHE A 338VAL A 524 | 1.50A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.78A | None | |||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.50A | 21.41 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.76A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU C 153LEU C 10THR C 13VAL C 144 | 1.57A | NoneNoneEDO C 205 ( 4.3A)None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN B 117VAL B 36LEU B 127CYH B 143THR B 146 | 1.60A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU C 164LEU C 169THR C 13VAL C 144 | 1.58A | NoneNoneEDO C 205 ( 4.3A)None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU E 153LEU E 10THR E 13VAL E 144 | 1.57A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN C 117VAL C 36LEU C 127CYH C 143THR C 146 | 1.55A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU D 164LEU D 169THR D 13VAL D 144 | 1.66A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU D 153LEU D 10THR D 13VAL D 144 | 1.59A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN A 117VAL A 36LEU A 127CYH A 143THR A 146 | 1.60A | NoneNoneEDO A 202 ( 4.8A)NoneNone | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN D 117LEU D 93LEU D 127CYH D 143THR D 146 | 1.72A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN C 117VAL C 36LEU C 127CYH C 143THR C 146 | 1.56A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN B 117VAL B 36LEU B 127CYH B 143THR B 146 | 1.60A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN E 117VAL E 36LEU E 127CYH E 143THR E 146 | 1.59A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU A 153LEU A 10THR A 13VAL A 144 | 1.61A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN E 117LEU E 93LEU E 127CYH E 143THR E 146 | 1.74A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN D 117VAL D 36LEU D 127CYH D 143THR D 146 | 1.58A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU C 127LEU C 122THR C 146VAL C 142 | 1.66A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN A 117VAL A 36LEU A 127CYH A 143THR A 146 | 1.60A | NoneNoneEDO A 202 ( 4.8A)NoneNone | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN D 117VAL D 36LEU D 127CYH D 143THR D 146 | 1.58A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU A 164LEU A 169THR A 13VAL A 144 | 1.61A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU B 153LEU B 10THR B 13VAL B 144 | 1.59A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU B 164LEU B 169THR B 13VAL B 144 | 1.58A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN B 117LEU B 93LEU B 127CYH B 143THR B 146 | 1.75A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN E 117VAL E 36LEU E 127CYH E 143THR E 146 | 1.59A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN C 117LEU C 93LEU C 127CYH C 143THR C 146 | 1.70A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU C 127LEU C 122THR C 146VAL C 142 | 1.64A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN D 117LEU D 93LEU D 127CYH D 143THR D 146 | 1.73A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU D 164LEU D 169THR D 13VAL D 144 | 1.66A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN C 117VAL C 36LEU C 127CYH C 143THR C 146 | 1.59A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN A 117VAL A 36LEU A 127CYH A 143THR A 146 | 1.61A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU D 127LEU D 122THR D 146VAL D 142 | 1.63A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN E 117VAL E 36LEU E 127CYH E 143THR E 146 | 1.58A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN E 117LEU E 93LEU E 127CYH E 143THR E 146 | 1.74A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN C 117VAL C 36LEU C 127CYH C 143THR C 146 | 1.59A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU E 153LEU E 10THR E 13VAL E 144 | 1.58A | NoneEDO E 203 ( 4.8A)NoneNone | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN A 117VAL A 36LEU A 127CYH A 143THR A 146 | 1.60A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN A 117LEU A 93LEU A 127CYH A 143THR A 146 | 1.75A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU B 164LEU B 169THR B 13VAL B 144 | 1.50A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN D 117VAL D 36LEU D 127CYH D 143THR D 146 | 1.59A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU E 164LEU E 169THR E 13VAL E 144 | 1.64A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU C 153LEU C 10THR C 13VAL C 144 | 1.58A | NoneEDO B 203 (-4.6A)NoneNone | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN B 117VAL B 36LEU B 127CYH B 143THR B 146 | 1.60A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU B 153LEU B 10THR B 13VAL B 144 | 1.56A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU A 153LEU A 10THR A 13VAL A 144 | 1.62A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN E 117VAL E 36LEU E 127CYH E 143THR E 146 | 1.58A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN D 117VAL D 36LEU D 127CYH D 143THR D 146 | 1.59A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN B 117LEU B 93LEU B 127CYH B 143THR B 146 | 1.77A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN C 117LEU C 93LEU C 127CYH C 143THR C 146 | 1.74A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU C 164LEU C 169THR C 13VAL C 144 | 1.53A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU A 127LEU A 122THR A 146VAL A 142 | 1.65A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU D 153LEU D 10THR D 13VAL D 144 | 1.61A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN B 117VAL B 36LEU B 127CYH B 143THR B 146 | 1.61A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU A 164LEU A 169THR A 13VAL A 144 | 1.57A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN A 117VAL A 36LEU A 127CYH A 143THR A 146 | 1.59A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN A 117VAL A 36LEU A 127CYH A 143THR A 146 | 1.59A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN C 117LEU C 93LEU C 127CYH C 143THR C 146 | 1.72A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU B 153LEU B 10THR B 13VAL B 144 | 1.58A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU A 153LEU A 10THR A 13VAL A 144 | 1.64A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU A 127LEU A 122THR A 146VAL A 142 | 1.66A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU A 164LEU A 169THR A 13VAL A 144 | 1.66A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN B 117VAL B 36LEU B 127CYH B 143THR B 146 | 1.58A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN C 117VAL C 36LEU C 127CYH C 143THR C 146 | 1.57A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 6 | LEU C 153LEU C 10THR C 13VAL C 144 | 1.61A | None | |||
![]() | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN B 117LEU B 93LEU B 127CYH B 143THR B 146 | 1.74A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN B 117VAL B 36LEU B 127CYH B 143THR B 146 | 1.58A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN C 117VAL C 36LEU C 127CYH C 143THR C 146 | 1.57A | None | |||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.45A | 19.50 | None | ||
![]() | 4UDC_A_DEXA1778_2 (GLUCOCORTICOIDRECEPTOR) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 3 / 3 | MET A 264GLN A 273TYR A 237 | 1.75A | 19.50 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.70A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.68A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.76A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 174VAL A 171CYH A 128ILE A 106PHE A 112 | 1.73A | None | |||
![]() | 3GN8_A_DEXA247_2 (GLUCOCORTICOIDRECEPTOR 2) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | MET A 463MET A 633PHE A 313 | 1.76A | 14.35 | None | ||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | MET A 666GLY A 670ARG A 392ILE A 539PHE A 504 | 1.42A | 14.03 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 7btf | NSP12 (SARS-CoV-2) | 4 / 6 | LEU A 212LEU A 146THR A 248VAL A 182 | 1.53A | None | |||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 214GLN A 210VAL A 182LEU A 178THR A 148 | 1.69A | None | |||
![]() | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | LEU A 786ALA A 762MET A 794CYH A 622PHE A 694 | 1.68A | 14.01 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 7btf | NSP12 (SARS-CoV-2) | 4 / 6 | LEU A 240TRP A 290LEU A 245THR A 189 | 1.53A | None | |||
![]() | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | MET A 666GLY A 670ARG A 392ILE A 539PHE A 504 | 1.53A | 13.61 | None | ||
![]() | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | MET A 666GLY A 670ARG A 392ILE A 539PHE A 504 | 1.63A | 14.67 | None | ||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 7btf | NSP12 (SARS-CoV-2) | 4 / 5 | LEU A 731TRP A 290MET A 242LEU A 240 | 1.55A | 14.67 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 7btf | NSP12 (SARS-CoV-2) | 4 / 6 | LEU A 731LEU A 723PHE A 745VAL A 472 | 1.51A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 214GLN A 210VAL A 182LEU A 178THR A 148 | 1.68A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 7btf | NSP7NSP8 (SARS-CoV-2) | 4 / 6 | LEU C 59LEU D 103THR C 9VAL C 12 | 1.47A | None | |||
![]() | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | MET A 666GLY A 670ARG A 392ILE A 539PHE A 504 | 1.47A | 14.67 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.67A | None | |||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.64A | None | |||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | MET A 264LEU A 205LEU A 242THR A 257ILE A 259 | 1.45A | 19.50 | None | ||
![]() | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | ASN A 695GLN A 789MET A 626MET A 633ILE A 757 | 1.76A | 13.33 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 7bv1 | NSP7NSP8 (SARS-CoV-2) | 4 / 6 | LEU C 59LEU D 103THR C 9VAL C 12 | 1.47A | None | |||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | LEU A 673LEU A 401GLY A 671MET A 542THR A 393 | 1.72A | 14.63 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 214GLN A 210VAL A 182LEU A 178THR A 148 | 1.64A | None | |||
![]() | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | MET A 666GLY A 670ARG A 392ILE A 539PHE A 504 | 1.38A | 14.63 | None | ||
![]() | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | MET A 666GLY A 670ARG A 392ILE A 539PHE A 504 | 1.47A | 14.63 | None | ||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 5 | LEU A 731TRP A 290MET A 242LEU A 240 | 1.56A | 14.63 | None | ||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | ASN A 695GLN A 789MET A 626MET A 633ILE A 757 | 1.74A | 13.90 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 6 | LEU A 212LEU A 146THR A 248VAL A 182 | 1.46A | None | |||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | MET A 666GLY A 670ARG A 392ILE A 539PHE A 504 | 1.32A | 13.90 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 6 | LEU A 731LEU A 723PHE A 745VAL A 472 | 1.48A | None | |||
![]() | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | LEU A 786ALA A 762MET A 794CYH A 622PHE A 694 | 1.66A | 12.69 | None | ||
![]() | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | MET A 666GLY A 670ARG A 392ILE A 539PHE A 504 | 1.42A | 13.33 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 214GLN A 210VAL A 182LEU A 178THR A 148 | 1.66A | None | |||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 6 | LEU A 240TRP A 290LEU A 245THR A 189 | 1.49A | None | |||
![]() | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | MET A 666GLY A 670ARG A 392ILE A 539PHE A 504 | 1.53A | 14.63 | None | ||
![]() | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | MET A 666GLY A 670ARG A 392ILE A 539PHE A 504 | 1.60A | 14.63 | None | ||
![]() | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | MET A 666GLY A 670ARG A 392ILE A 539PHE A 504 | 1.43A | 14.63 | None | ||
![]() | 3GN8_A_DEXA247_2 (GLUCOCORTICOIDRECEPTOR 2) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | MET A 463MET A 633PHE A 313 | 1.74A | 13.09 | None | ||
![]() | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 214GLN A 210VAL A 182LEU A 178THR A 148 | 1.66A | None | |||
![]() | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | LEU A 673LEU A 401GLY A 671MET A 542THR A 393 | 1.63A | 14.63 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 6 | LEU A 212LEU A 146THR A 248VAL A 182 | 1.50A | None | |||
![]() | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | ASN A 695GLN A 789MET A 626MET A 633ILE A 757 | 1.68A | 13.33 | None | ||
![]() | 3GN8_A_DEXA247_2 (GLUCOCORTICOIDRECEPTOR 2) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | MET A 633MET A 463PHE A 694 | 1.76A | 13.09 | None | ||
![]() | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 214GLN A 210VAL A 182LEU A 178THR A 148 | 1.65A | None | |||
![]() | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | MET A 666GLY A 670ARG A 392ILE A 539PHE A 504 | 1.53A | 14.63 | None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 6 | LEU A 240TRP A 290LEU A 245THR A 189 | 1.55A | None | |||
![]() | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | LEU A 786ALA A 762MET A 794CYH A 622PHE A 694 | 1.68A | 12.69 | NoneNoneNoneF86 P 102 ( 4.6A)None | ||
![]() | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 6 | LEU A 731LEU A 723PHE A 745VAL A 472 | 1.55A | None | |||
![]() | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | ASN A 695GLN A 789MET A 626MET A 633ILE A 757 | 1.67A | 13.90 | None | ||
![]() | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 5 | LEU A 731TRP A 290MET A 242LEU A 240 | 1.52A | 14.63 | None |